Using serum samples obtained from normal individuals who had not received heparin injection, we investigated the relationship of lipoprotein lipase (LPL) to lipid and apolipoprotein concentrations in serum. For the measurement of LPL concentration, a highly sensitive enzyme-linked immunosorbent assay (ELISA) was developed, in which the lowest detection limit was 9 μg/L. The mean (SD) serum LPL concentration was 50·7 (14·9) μg/L (n = 240). It was lower in men [45·5 (14·0) μg/L in men and 56·0 (13·9) μg/L in women]. Serum LPL concentration correlated positively with high-density lipoprotein cholesterol (HDL-C, r = 0·549) and apolipoprotein AI (apoAI, r = 0·487), and inversely with triglycerides (r = −0·423). Our results suggest that serum LPL may be a factor in the modulation of HDL-C and triglyceride concentrations in normal subjects.
OlivecronaTBengtsson-OlivecronaG.Lipoprotein lipase and hepatic lipase. Curr Opin Lipidol1993; 4: 187–96.
2.
GoldbergIJ.Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. J Lipid Res.1996; 37: 693–707.
3.
GoldbergIJLeN-AGinsbergHNKraussRMLindgrenFT.Lipoprotein metabolism during acute inhibition of lipoprotein lipase in the cynomolgus monkey. J Clin Invest1988; 81: 561–8.
4.
PatschJRGottoAMJrOlivecronaTEisenbergS.Formation of high density lipoprotein2-like particles during lipolysis of very low density lipoproteins in vitro. Proc Natl Acad Sci USA1978; 75: 4519–23.
5.
MurdochSJBreckenridgeWC.Influence of lipoprotein lipase and hepatic lipase on the transformation of VLDL and HDL during lipolysis of VLDL. Atherosclerosis1995; 118: 193–212.
6.
FisherRMMaillyFPeacockREHamstenASeedMYudkinJSInteraction of the lipoprotein lipase asparagine 291 → serine mutation with body mass index determines elevated plasma triacylglycerol concentrations: a study in hyperlipidemic subjects, myocardial infarction survivors, and healthy adults. J Lipid Res.1996; 36: 2104–12.
TaskinenM-RNikkilaEA.High density lipoprotein subfractions in relation to lipoprotein lipase activity of tissues in man—evidence for reciprocal regulation of HDL2 and HDL, levels by lipoprotein lipase. Clin Chim Acta1981; 112: 325–32.
9.
BladesBVegaGLGrundySM.Activities of lipoprotein lipase and hepatic triglyceride lipase in postheparin plasma of patients with low concentrations of HDL cholesterol. Arterioscler Thromb1993; 13: 1227–35.
10.
TornvallPOlivecronaGKarpeFOlivecronaT.Lipoprotein lipase mass and activity in plasma and their increase after heparin arc separate parameters with different relations to plasma lipoproteins. Arterioscler Thromb Vasc Biol1995; 5: 1086–93.
11.
MillerNEThelleDSFordeOHMjosOD.The Tromsø heart study. High-density lipoprotein and coronary heart disease: a prospective case-control study. Lancet1977; i: 965–8.
12.
GordonTCastelliWPHjortlandMCKannelWBDawberTR.High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med.1977; 62: 707–14.
13.
CastelliWP.The triglyceride issue: a view from Framingham. Am Heart J1986; 112: 432–7.
14.
TatoFVegaGLGrundySM.Determinants of plasma HDL-cholesterol in hypertriglyceridemic patients. Arterioscler Thromb Vasc Biol1997; 17: 56–63.
15.
KobayashiJHashimotoHFukamachiITashiroJShiraiKSaitoYLipoprotein lipase mass and activity in severe hypertriglyceridemia. Clin Chim Acta1993; 216: 113–23.
16.
HinoKNakamuraMNakanishiKManabeM.A new method for the homogeneous assay of serum HDL-cholesterol. Clin Chem1996; 42: S299.
17.
FriedewaldWTLevyRI.Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem1972; 18: 499–502.
18.
WatsonTDGTanC-EMcConnellMCleggSKSquiresLFPackardCJ.Measurement and physiological significance of lipoprotein and hepatic lipase activities in preheparin plasma. Clin Chem1995; 41: 405–12.
19.
RcymerPWAGagneEGrocnemeycrBEZhangHForsythIJansenHA lipoprotein lipase mutation (Asn291Ser) is associated with reduced HDL cholesterol levels in premature atherosclerosis. Nature Genet1995; 10: 28–34.
